{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"152"},{"groupId":"OG001","value":"43"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"231"},{"groupId":"OG001","value":"112"}],"units":"Participants"}],"description":"Crohn's Disease Activity Index (CDAI)-100 response was defined as a decrease in CDAI score of 100 points or more from the baseline value.\n\nThe total CDAI scores range from 0 to over 600 with higher scores indicating increased severity of disease. The index is the sum of 8 components; number of liquid or very soft stools, abdominal pain, general well-being, CD complications, taking antidiarrheal drugs, abdominal mass, hematocrit, and weight.\n\nPatients with dose adjustment to CT-P13 SC 240 mg prior to Week 54 were considered as non-responder.","groups":[{"description":"CT-P13 SC 120 mg","id":"OG000","title":"CT-P13 SC 120 mg"},{"description":"Placebo","id":"OG001","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All-randomized population","reportingStatus":"POSTED","timeFrame":"Week 54","title":"Percentage of Patients Achieving CDAI-100 Response at Week 54","type":"SECONDARY","unitOfMeasure":"Participants"}